EP3935068
ABIRATERONE PRODRUGS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
4.3.2020EP published:
6.9.2023EP application number:
20717363.4
EPO information:
European Patent Register
Max expiry date:
3.3.2040
Title in English:
ABIRATERONE PRODRUGSLanguage of the patent:
English
Timeline
Today
4.3.2020EP application
6.9.2023EP Publication
Owner
Name:
Propella Therapeutics, Inc.Address:
480 Hillsboro Street Suite 130A, Pittsboro NC 27312, US
Inventor
Name:
SHARP, Matthew, J.Address:
Pittsboro, NC 27312, US
Name:
MOORE, William, R.Address:
Pittsboro, NC 27312, US
Priority
Number:
201962814568 PDate:
6.3.2019Country:
US
Number:
201962849259 PDate:
17.5.2019Country:
US
Classification
Categories:
C07J 43/00, A61K 31/58, A61P 5/28, A61P 5/46, A61P 35/00